195 related articles for article (PubMed ID: 25255395)
1. Potential cost-effectiveness of therapeutic drug monitoring in patients with resistant hypertension.
Chung O; Vongpatanasin W; Bonaventura K; Lotan Y; Sohns C; Haverkamp W; Dorenkamp M
J Hypertens; 2014 Dec; 32(12):2411-21; discussion 2421. PubMed ID: 25255395
[TBL] [Abstract][Full Text] [Related]
2. Potential lifetime cost-effectiveness of catheter-based renal sympathetic denervation in patients with resistant hypertension.
Dorenkamp M; Bonaventura K; Leber AW; Boldt J; Sohns C; Boldt LH; Haverkamp W; Frei U; Roser M
Eur Heart J; 2013 Feb; 34(6):451-61. PubMed ID: 23091202
[TBL] [Abstract][Full Text] [Related]
3. Telemonitoring and self-management in the control of hypertension (TASMINH2): a cost-effectiveness analysis.
Kaambwa B; Bryan S; Jowett S; Mant J; Bray EP; Hobbs FD; Holder R; Jones MI; Little P; Williams B; McManus RJ
Eur J Prev Cardiol; 2014 Dec; 21(12):1517-30. PubMed ID: 23990660
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of self-management of blood pressure in hypertensive patients over 70 years with suboptimal control and established cardiovascular disease or additional cardiovascular risk diseases (TASMIN-SR).
Penaloza-Ramos MC; Jowett S; Mant J; Schwartz C; Bray EP; Sayeed Haque M; Richard Hobbs FD; Little P; Bryan S; Williams B; McManus RJ
Eur J Prev Cardiol; 2016 Jun; 23(9):902-12. PubMed ID: 26603745
[TBL] [Abstract][Full Text] [Related]
5. Cost effectiveness of therapeutic drug monitoring for imatinib administration in chronic myeloid leukemia.
Kim K; McMillin GA; Bernard PS; Tantravahi S; Walker BS; Schmidt RL
PLoS One; 2019; 14(12):e0226552. PubMed ID: 31869360
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of noninvasive central blood pressure monitoring in the diagnosis of hypertension.
Cheng HM; Pearson A; Sung SH; Yu WC; Chen CH; Karnon J
Am J Hypertens; 2015 May; 28(5):604-14. PubMed ID: 25430695
[TBL] [Abstract][Full Text] [Related]
7. The Cost-Effectiveness of Low-Cost Essential Antihypertensive Medicines for Hypertension Control in China: A Modelling Study.
Gu D; He J; Coxson PG; Rasmussen PW; Huang C; Thanataveerat A; Tzong KY; Xiong J; Wang M; Zhao D; Goldman L; Moran AE
PLoS Med; 2015 Aug; 12(8):e1001860. PubMed ID: 26241895
[TBL] [Abstract][Full Text] [Related]
8. Cost-Effectiveness of Renal Denervation Therapy for Treatment-Resistant Hypertension: A Best Case Scenario.
Chowdhury EK; Reid CM; Zomer E; Kelly DJ; Liew D
Am J Hypertens; 2018 Sep; 31(10):1156-1163. PubMed ID: 30010694
[TBL] [Abstract][Full Text] [Related]
9. The cost-effectiveness of therapeutic drug monitoring for the prescription drug-based treatment of chronic myeloid leukemia.
Conti RM; Padula WV; Becker RV; Salamone S
J Manag Care Spec Pharm; 2021 Aug; 27(8):1077-1085. PubMed ID: 34337991
[No Abstract] [Full Text] [Related]
10. Cost effectiveness of an adherence-improving programme in hypertensive patients.
Brunenberg DE; Wetzels GE; Nelemans PJ; Dirksen CD; Severens JL; Stoffers HE; Schouten JS; Prins MH; de Leeuw PW; Joore MA
Pharmacoeconomics; 2007; 25(3):239-51. PubMed ID: 17335309
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of adding novel or group 5 interventions to a background regimen for the treatment of multidrug-resistant tuberculosis in Germany.
Wirth D; Dass R; Hettle R
BMC Health Serv Res; 2017 Mar; 17(1):182. PubMed ID: 28270207
[TBL] [Abstract][Full Text] [Related]
12. Cost-Utility of an Objective Biochemical Measure to Improve Adherence to Antihypertensive Treatment.
van Schoonhoven AV; van Asselt ADI; Tomaszewski M; Patel P; Khunti K; Gupta P; Postma MJ
Hypertension; 2018 Nov; 72(5):1117-1124. PubMed ID: 30354817
[TBL] [Abstract][Full Text] [Related]
13. Comparative Cost-Effectiveness of Conservative or Intensive Blood Pressure Treatment Guidelines in Adults Aged 35-74 Years: The Cardiovascular Disease Policy Model.
Moise N; Huang C; Rodgers A; Kohli-Lynch CN; Tzong KY; Coxson PG; Bibbins-Domingo K; Goldman L; Moran AE
Hypertension; 2016 Jul; 68(1):88-96. PubMed ID: 27181996
[TBL] [Abstract][Full Text] [Related]
14. Cost-Effectiveness of Telemonitoring and Self-Monitoring of Blood Pressure for Antihypertensive Titration in Primary Care (TASMINH4).
Monahan M; Jowett S; Nickless A; Franssen M; Grant S; Greenfield S; Hobbs FDR; Hodgkinson J; Mant J; McManus RJ
Hypertension; 2019 Jun; 73(6):1231-1239. PubMed ID: 31067190
[TBL] [Abstract][Full Text] [Related]
15. Cost-Effectiveness of Therapeutic Drug Monitoring in Diagnosing Primary Aldosteronism in Patients With Resistant Hypertension.
Velasco A; Chung O; Raza F; Pandey A; Brinker S; Arbique D; Price A; Lotan Y; Das SR; Vongpatanasin W
J Clin Hypertens (Greenwich); 2015 Sep; 17(9):713-9. PubMed ID: 25917401
[TBL] [Abstract][Full Text] [Related]
16. Which is more important for the efficiency of hypertension treatment: hypertension stage, type of drug or therapeutic compliance?
Mar J; Rodríguez-Artalejo F
J Hypertens; 2001 Jan; 19(1):149-55. PubMed ID: 11204296
[TBL] [Abstract][Full Text] [Related]
17. Cost-Effectiveness of Screening for Primary Aldosteronism and Subtype Diagnosis in the Resistant Hypertensive Patients.
Lubitz CC; Economopoulos KP; Sy S; Johanson C; Kunzel HE; Reincke M; Gazelle GS; Weinstein MC; Gaziano TA
Circ Cardiovasc Qual Outcomes; 2015 Nov; 8(6):621-30. PubMed ID: 26555126
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of renin-guided treatment of hypertension.
Smith SM; Campbell JD
Am J Hypertens; 2013 Nov; 26(11):1303-10. PubMed ID: 24048147
[TBL] [Abstract][Full Text] [Related]
19. Cost-Effectiveness of Initiating Pharmacological Treatment in Stage One Hypertension Based on 10-Year Cardiovascular Disease Risk: A Markov Modeling Study.
Constanti M; Floyd CN; Glover M; Boffa R; Wierzbicki AS; McManus RJ
Hypertension; 2021 Feb; 77(2):682-691. PubMed ID: 33342242
[TBL] [Abstract][Full Text] [Related]
20. Direct healthcare costs and cost-effectiveness of acute coronary syndrome secondary prevention with ticagrelor compared to clopidogrel: economic evaluation from the public payer's perspective in Poland based on the PLATO trial results.
Pawęska J; Macioch T; Perkowski P; Budaj A; Niewada M
Kardiol Pol; 2014; 72(9):823-30. PubMed ID: 24846362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
